[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369672-105":59,"doc-detail-369672-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","emerin-expression-stratification-across-breast-cancer-subtypes-read-online-free","Emerin expression stratification across breast cancer subtypes - read online free","","Nuclear dysmorphism serves as a critical marker of tumor aggressiveness, shaping invasion and metastasis. Emerin, a nuclear envelope protein essential for nuclear architecture and integrity, shows an inverse relationship with breast cancer aggressiveness, but prior work lacked power to test links to stage, grade, proliferation, or molecular phenotype. This study quantifies emerin at the nuclear envelope across 243 patient samples and finds reduced emerin in multiple disease types, with loss tracking advanced stage, higher Ki-67, higher HER2, and lower ER/PR, including consistent reduction in TNBC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/emerin-expression-stratification-across-breast-cancer-subtypes-read-online-free/369672/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/emerin-expression-stratification-across-breast-cancer-subtypes-read-online-free/369672.png","ImageObject",300,407,{"name":92,"@type":93},"Terk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of stratifying emerin expression across breast cancer subtypes?","Question",{"text":112,"@type":113},"The study evaluates how emerin expression at the nuclear envelope relates to tumor aggressiveness and key clinical or molecular features across breast cancer subtypes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was emerin expression assessed in this work?",{"text":117,"@type":113},"Emerein expression was analyzed at the nuclear envelope across 243 breast cancer patient samples, with results compared across grades, stages, and molecular phenotypes.",{"name":119,"@type":110,"acceptedAnswer":120},"Which breast cancer features showed correlation with emerin loss?",{"text":121,"@type":113},"Emerin loss correlated with advanced tumor stage, higher Ki-67 proliferation rates, elevated HER2 levels, and decreased ER and PR expression, and it was consistently reduced in TNBC and other receptor-negative subtypes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369672,1790653614,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":41,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","bioRxiv preprint doi: [https://doi.org/10.1101/2025.07.03.663032](https://doi.org/10.1101/2025.07.03.663032); this version posted July 7, 2025. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under aCC-BY-NC-ND 4.0 International license.  \n1 Emerin expression stratification across breast cancer subtypes 2  \n3 Thaysa Ghiarone 1\\#, Emily Hansen 1,2\\# , James M. Holaska* 1,2 4  \n5 1 Department of Biomedical Sciences, Cooper Medical School of Rowan University, 6 Camden, NJ, 2 Molecular Cell Biology and Neuroscience Program, Rowan-Virtua School  \n7 of Translational Biomedical Engineering and Sciences, Stratford, NJ , \\#These authors  \n8 contributed equally to this work.  \n9  \n10 *To whom correspondence should be addressed:  \n11 James M. Holaska  \n12 Cooper Medical School of Rowan University  \n13 Department of Biomedical Sciences, MEB 534  \n14 401 South Broadway  \n15 Camden, NJ. 08103  \n16 856-956-2746  \n17 [holaska@rowan.edu](holaska@rowan.edu)[ ](holaska@rowan.edu)18  \n19 Keywords: Emerin, nucleoskeleton, metastasis, breast cancer  \n20 Word Count: 20,585 characters, including spaces  \n21 Figures and Tables: 4 figures  \n22 Conflicts of Interest:  \n23 Authors have no conflicts of interest to disclose.  \nbioRxiv preprint doi: [https://doi.org/10.1101/2025.07.03.663032](https://doi.org/10.1101/2025.07.03.663032); this version posted July 7, 2025. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under aCC-BY-NC-ND 4.0 International license.  \n24 Acknowledgements:  \n25 We thank the Department of Biomedical Sciences at Cooper Medical School of Rowan  \n26 University for providing funding for this work and many fruitful discussions. We thank Dr.  \n27 Isabelle Mercier (St. Joseph’s University) for many fruitful discussions regarding these  \n28 studies. We thank the members of Holaska’s lab for the numerous discussions  \n29 pertaining to this manuscript and the Boehning lab (Cooper Medical School at Rowan  \n30 University) for technical help as needed during experiments.  \n31 Author Contributions:  \n32 J. M. H. , T.G.S. , and E. H. conceived the project. T.G.S. and E. H. performed the IHC  \n33 experiments and T.S.G. , E. H. , and J. M. H. analyzed the data in the IHC experiments. All  \n34 authors contributed input in figure preparation and in writing of the manuscript.  \n35 Funding:  \n36 This work was supported by a grant from the National Institute of Arthritis, and  \n37 Musculoskeletal and Skin Diseases (R15AR069935 to J. M. H.) , a grant from the New  \n38 Jersey Commission on Cancer Research (COCR22RBG007 to J. M. H.) , and a pre-  \n39 doctoral grant from the New Jersey Commission on Cancer Research  \n40 (COCR25PRF018 to E. H.) . The content is solely the responsibility of the authors and  \n41 does not necessarily represent the official views of the National Institutes of Health or  \n42 the New Jersey Commission on Cancer Research. This work was also supported by  \n43 Rowan University under the Camden Health Research Initiative (to J. M. H.) .  \n44 Competing Interests:  \n45 The authors declare no competing interests.  \nbioRxiv preprint doi: [https://doi.org/10.1101/2025.07.03.663032](https://doi.org/10.1101/2025.07.03.663032); this version posted July 7, 2025. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made  \navailable under aCC-BY-NC-ND 4.0 International license.  \n46 Data Availability:  \n47 The data supporting the findings of this study are available by request from the  \n48 corresponding author, J.M. H.  \nbioRxiv preprint doi: [https://doi.org/10.1101/2025.07.03.663032](https://doi.org/10.1101/2025.07.03.663","cbCaijGXa2pCMy1L","https://ap.wps.com/l/cbCaijGXa2pCMy1L","pdf",3132331,"English","# Abstract\n## Keywords\n## Acknowledgements\n## Author Contributions\n## Funding\n## Competing Interests\n## Data Availability","[{\"question\":\"What is the main purpose of stratifying emerin expression across breast cancer subtypes?\",\"answer\":\"The study evaluates how emerin expression at the nuclear envelope relates to tumor aggressiveness and key clinical or molecular features across breast cancer subtypes.\"},{\"question\":\"How was emerin expression assessed in this work?\",\"answer\":\"Emerein expression was analyzed at the nuclear envelope across 243 breast cancer patient samples, with results compared across grades, stages, and molecular phenotypes.\"},{\"question\":\"Which breast cancer features showed correlation with emerin loss?\",\"answer\":\"Emerin loss correlated with advanced tumor stage, higher Ki-67 proliferation rates, elevated HER2 levels, and decreased ER and PR expression, and it was consistently reduced in TNBC and other receptor-negative subtypes.\"}]","Emerin expression stratification across breast cancer subtypes - read online free | PDF",1790184042,76,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1ec896ffa949f01aaec8ae5fa7b92c2.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3890f53b6adbfc12994728bcc8460bee.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79011a3f2fdd7611fede2b560abfeaa2.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/767bbeb0bd05744614b922487e09cb3e.webp",980,1268]